Your session is about to expire
← Back to Search
Procedure
3D Printing + Conventional Imaging for Hip Surgery Planning
N/A
Waitlist Available
Led By Ivan Wong, Dr.
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Patients with type III or IV heterotopic ossification
Patients with nonvascular surgical sites (MRI proven)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pre-op measurements compared to 24 months post-operatively
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether 3D printed models can help with planning for arthroscopic FAI surgery. Patients will be randomly assigned to either have just conventional imaging or to have a 3D printed model in addition.
Who is the study for?
This trial is for individuals with a confirmed diagnosis of cam-type femoroacetabular impingement (FAI) using radiology. It's not suitable for those who are pregnant, unable to consent, have infections, don't understand post-op care, have cancer or advanced arthritis, heterotopic ossification types III/IV, need revision surgery, nonvascular surgical sites or avascular necrosis.
What is being tested?
The study compares two approaches in planning hip preservation surgery: one group uses standard imaging techniques like X-ray and MRI only; the other group gets a personalized 3D printed model based on these images as well. Patients will be randomly assigned to either group.
What are the potential side effects?
Since this trial focuses on preoperative planning methods rather than medications or invasive procedures directly administered to patients, there are no direct side effects from the interventions being tested.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have advanced heterotopic ossification.
Select...
My surgery site is not related to blood vessels, confirmed by MRI.
Select...
I have avascular necrosis.
Select...
I have severe arthritis as shown by my X-rays.
Select...
I cannot follow or understand post-surgery instructions.
Select...
I am scheduled for a second hip surgery to correct a previous one.
Select...
I am unable to understand and give consent for my treatment.
Select...
I currently have an infection.
Select...
I have a hip cartilage injury larger than 1cm2.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in pre-op measurements compared to 24 months post-operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pre-op measurements compared to 24 months post-operatively
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measure of CAM resection
Secondary study objectives
Differences in post-operative patient reported outcomes: EQ5D
Differences in post-operative patient reported outcomes: EQ5D-VAS
Differences in post-operative patient reported outcomes: HOS-Sport
+4 moreOther study objectives
The number of times conventional imaging and 3D prints are referenced intra-operatively.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Conventional ImagingExperimental Treatment1 Intervention
Patients in this group allocation will receive conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.
Group II: 3D Print + Conventional imagingExperimental Treatment1 Intervention
Patients in this group allocation will receive a 3D reconstruction of their hip in addition to conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,482 Total Patients Enrolled
Ivan Wong, Dr.Principal InvestigatorNova Scotia Health Authority
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My surgery site is not related to blood vessels, confirmed by MRI.I have advanced heterotopic ossification.I have avascular necrosis.I have severe arthritis as shown by my X-rays.I cannot follow or understand post-surgery instructions.I am scheduled for a second hip surgery to correct a previous one.I am unable to understand and give consent for my treatment.I currently have an infection.I have a hip cartilage injury larger than 1cm2.I have cancer.
Research Study Groups:
This trial has the following groups:- Group 1: 3D Print + Conventional imaging
- Group 2: Conventional Imaging
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.